- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
GlaxoSmithKline Pharmaceuticals Limited has announced a board meeting outcome approving audited standalone and consolidated financial results for the year. Consolidated revenue stood at Rs. 3,74,921 lakhs with a profit after tax of Rs. 92,758 lakhs, showing strong annual growth. A final dividend of Rs. 42 per equity share has been declared. Dr. (Ms.) Sunita Maheshwari has been re-appointed as an Independent Director for another three-year term. Parikh & Associates is appointed as the Secretarial Auditor for five years from FY 2025-26. Statutory auditors issued clean opinions on the results.
All announcements from GlaxoSmithKline Pharmaceuticals Limited